1. Home
  2. KROS vs MATW Comparison

KROS vs MATW Comparison

Compare KROS & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • MATW
  • Stock Information
  • Founded
  • KROS 2015
  • MATW 1850
  • Country
  • KROS United States
  • MATW United States
  • Employees
  • KROS N/A
  • MATW N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • MATW Metal Fabrications
  • Sector
  • KROS Health Care
  • MATW Telecommunications
  • Exchange
  • KROS Nasdaq
  • MATW Nasdaq
  • Market Cap
  • KROS 558.9M
  • MATW 654.6M
  • IPO Year
  • KROS 2020
  • MATW 1994
  • Fundamental
  • Price
  • KROS $13.37
  • MATW $24.69
  • Analyst Decision
  • KROS Buy
  • MATW Strong Buy
  • Analyst Count
  • KROS 13
  • MATW 1
  • Target Price
  • KROS $20.63
  • MATW $40.00
  • AVG Volume (30 Days)
  • KROS 637.6K
  • MATW 217.5K
  • Earning Date
  • KROS 08-06-2025
  • MATW 07-31-2025
  • Dividend Yield
  • KROS N/A
  • MATW 4.18%
  • EPS Growth
  • KROS N/A
  • MATW N/A
  • EPS
  • KROS 0.11
  • MATW N/A
  • Revenue
  • KROS $214,713,000.00
  • MATW $1,703,999,000.00
  • Revenue This Year
  • KROS $5,006.76
  • MATW N/A
  • Revenue Next Year
  • KROS N/A
  • MATW N/A
  • P/E Ratio
  • KROS $123.16
  • MATW N/A
  • Revenue Growth
  • KROS 91657.70
  • MATW N/A
  • 52 Week Low
  • KROS $9.12
  • MATW $18.50
  • 52 Week High
  • KROS $72.37
  • MATW $32.24
  • Technical
  • Relative Strength Index (RSI)
  • KROS 42.27
  • MATW 62.23
  • Support Level
  • KROS $13.25
  • MATW $23.52
  • Resistance Level
  • KROS $13.99
  • MATW $24.59
  • Average True Range (ATR)
  • KROS 0.36
  • MATW 0.76
  • MACD
  • KROS -0.06
  • MATW 0.20
  • Stochastic Oscillator
  • KROS 20.75
  • MATW 75.97

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

Share on Social Networks: